Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single- Center Experience
3
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Type 2 autoimmune pancreatitis (AIP) has been considered extremely rare in East Asia. This study aimed to clarify the prevalence, clinical characteristics and radiological findings of type 2 AIP highlighting patients presenting as acute pancreatitis in a single center. Methods: Type 2 AIP patients were classified according to International Consensus Diagnostic Criteria. Radiological findings were compared between type 2 AIP presenting as acute pancreatitis and gallstone pancreatitis. Results: Among 244 patients with AIP, 27 (11.1%) had type 2 AIP (definite, 15 [55.5%] and probable 12 [44.5%]). The median age of patients with type 2 AIP was 29 years (interquartile range, 20 to 39 years). Acute pancreatitis was the most common initial presentation (n=17, 63%) while obstructive jaundice was present in only one patient. Ulcerative colitis (UC) was associated with type 2 AIP in 44.4% (12/27) of patients. Radiological pancreatic imaging such as delayed enhancement of diffusely enlarged pancreas, homogeneous enhancement of focal enlargement/ mass, absent/minimal peripancreatic fat infiltration or fluid collection, and multifocal main pancreatic duct narrowings were helpful for differentiating type 2 AIP from gallstone pancreatitis. During follow-up (median, 32.3 months), two patients (2/25, 8%) experienced relapse. Conclusions: In South Korea, type 2 AIP is not as rare as previously thought. Overall, the clinical profile of type 2 AIP was similar to that of Western countries. Type 2 AIP should be considered in young UC patients with acute pancreatitis of uncertain etiology.
Abstract
Background/Aims: Type 2 autoimmune pancreatitis (AIP) has been considered extremely rare in East Asia. This study aimed to clarify the prevalence, clinical characteristics and radiological findings of type 2 AIP highlighting patients presenting as acute pancreatitis in a single center. Methods: Type 2 AIP patients were classified according to International Consensus Diagnostic Criteria. Radiological findings were compared between type 2 AIP presenting as acute pancreatitis and gallstone pancreatitis. Results: Among 244 patients with AIP, 27 (11.1%) had type 2 AIP (definite, 15 [55.5%] and probable 12 [44.5%]). The median age of patients with type 2 AIP was 29 years (interquartile range, 20 to 39 years). Acute pancreatitis was the most common initial presentation (n=17, 63%) while obstructive jaundice was present in only one patient. Ulcerative colitis (UC) was associated with type 2 AIP in 44.4% (12/27) of patients. Radiological pancreatic imaging such as delayed enhancement of diffusely enlarged pancreas, homogeneous enhancement of focal enlargement/ mass, absent/minimal peripancreatic fat infiltration or fluid collection, and multifocal main pancreatic duct narrowings were helpful for differentiating type 2 AIP from gallstone pancreatitis. During follow-up (median, 32.3 months), two patients (2/25, 8%) experienced relapse. Conclusions: In South Korea, type 2 AIP is not as rare as previously thought. Overall, the clinical profile of type 2 AIP was similar to that of Western countries. Type 2 AIP should be considered in young UC patients with acute pancreatitis of uncertain etiology.
참고문헌 (30)
- Madhani K, "Autoimmune pancreatitis : an update on diagnosis and management", Gastroenterol Clin North Am, 45, pp.29~43 (2016)
- Song TJ, "Clinical validation of the International Consensus Diagnostic Criteria and algorithms for autoimmune pancreatitis: combined IAP and KPBA meeting 2013 report", Pancreatology, 14, pp.233~237 (2014)
- Hart PA, "Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis(type 2 autoimmune pancreatitis) : the Mayo Clinic experience", Gut, 65, pp.1702~1709 (2016)
- Kamisawa T, "Clinical profile of autoimmune pancreatitis and its histological subtypes : an international multicenter survey", Pancreas, 40, pp.809~814 (2011)
- Song TJ, "Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis", J Gastroenterol Hepatol, 27, pp.700~708 (2012)
- Notohara K, "Clinicopathological features of type 2 autoimmune pancreatitis in Japan : results of a multicenter survey", Pancreas, 44, pp.1072~1077 (2015)
- Kamisawa T, "Recent advances in autoimmune pancreatitis : type 1 and type 2", Gut, 62, pp.1373~1380 (2013)
- Shimosegawa T, "International Consensus Diagnostic Criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
- Chari ST, "Diagnosis of autoimmune pancreatitis : the Mayo Clinic experience", Clin Gastroenterol Hepatol, 4, pp.1010~1016 (2006)
- Otsuki M, "Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis", J Gastroenterol, 43, pp.403~408 (2008)
- Tenner S, "American College of Gastroenterology guideline:management of acute pancreatitis", Am J Gastroenterol, 108, pp.1400~1415 (2013)
- Forsmark CE, "AGA Institute technical review on acute pancreatitis", Gastroenterology, 132, pp.2022~2044 (2007)
- Frulloni L, "Autoimmune pancreatitis : differences between the focal and diffuse forms in 87 patients", Am J Gastroenterol, 104, pp.2288~2294 (2009)
- Lee-Felker SA, "Use of MDCT to differentiate autoimmune pancreatitis from ductal adenocarcinoma and interstitial pancreatitis", AJR Am J Roentgenol, 205, pp.2~9 (2015)
- Takahashi N, "Autoimmune pancreatitis : differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT", AJR Am J Roentgenol, 193, pp.479~484 (2009)
- Edge MD, "Clinical significance of main pancreatic duct dilation on computed tomography : single and double duct dilation", World J Gastroenterol, 13, pp.1701~1705 (2007)
- Kim JW, "Clinical course of ulcerative colitis patients who develop acute pancreatitis", World J Gastroenterol, 23, pp.3505~3512 (2017)
- Moon SH, "Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study", Gut, 57, pp.1704~1712 (2008)
- Maire F, "Outcome of patients with type 1 or 2 autoimmune pancreatitis", Am J Gastroenterol, 106, pp.151~156 (2011)
- Petzold G, "Autoimmune pancreatitis in Germany : rare but relevant", Digestion, 96, pp.185~186 (2017)
- Sah RP, "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis", Gastroenterology, 139, pp.140~148 (2010)
- Hart PA, "Long-term outcomes of autoimmune pancreatitis : a multicentre, international analysis", Gut, 62, pp.1771~1776 (2013)
- Graziani R, "Autoimmune pancreatitis and non-necrotizing acute pancreatitis : computed tomography pattern", Dig Liver Dis, 44, pp.759~766 (2012)
- "CT and MR features of autoimmune pancreatitis" (2013)[URL]
- Park SH, "Magnetic resonance cholangiopancreatography for the diagnostic evaluation of autoimmune pancreatitis", Pancreas, 39, pp.1191~1198 (2010)
- Kim JH, "Pancreatic duct in autoimmune pancreatitis: intraindividual comparison of magnetic resonance pancreatography at 1.5 T and 3.0 T", Pancreas, 46, pp.921~926 (2017)
- Yanagisawa S, "Usefulness of threedimensional magnetic resonance cholangiopancreatography with partial maximum intensity projection for diagnosing autoimmune pancreatitis", Pancreatology, 17, pp.567~571 (2017)
- Lorenzo D, "Features of autoimmune pancreatitis associated with inflammatory bowel diseases", Clin Gastroenterol Hepatol, 16, pp.59~67 (2018)
- Ueki T, "Prevalence and clinicopathological features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease", Pancreas, 44, pp.434~440 (2015)
- Kawa S, "Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis", J Gastroenterol, 50, pp.805~815 (2015)